Piramal Pharma Limited has informed the Exchange about Change in Company Secretary and Compliance Officer
PPLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Piramal Pharma Limited has informed the stock exchange about a change in the position of Company Secretary and Compliance Officer. The Company Secretary and Compliance Officer is a Key Managerial Personnel (KMP) under the Companies Act, responsible for ensuring regulatory compliance and board-level governance. The specific details of the outgoing and incoming officials, including effective dates, are not available in the headline provided. This is a routine corporate governance disclosure required under SEBI listing regulations whenever a KMP change occurs.
Company Secretary changes are common and usually have limited direct impact on stock price, but shareholders may want to watch for any related governance concerns or disclosures about the reason for the change. No immediate material impact on business operations is expected.